Literature DB >> 11295493

The substrate translocation channel of the proteasome.

A Köhler1, M Bajorek, M Groll, L Moroder, D M Rubin, R Huber, M H Glickman, D Finley.   

Abstract

The core particle (CP) of the yeast proteasome is composed of four heptameric rings of subunits arranged in a hollow, barrel-like structure. We have found that the CP is autoinhibited by the N-terminal tails of the outer (alpha) ring subunits. Crystallographic analysis showed that deletion of the tail of the alpha3 subunit opens a channel into the proteolytically active interior chamber of the CP, thus derepressing peptide hydrolysis. In the latent state of the particle, the tails prevent substrate entry by imposing topological closure on the CP. Inhibition by the alpha subunit tails is relieved upon binding of the regulatory particle to the CP to form the proteasome holoenzyme. Opening of the CP channel by assembly of the holoenzyme is regulated by the ATPase domain of Rpt2, one of 17 subunits in the RP. Thus, open-channel mutations in CP subunits suppress the closed-channel phenotype of an rpt2 mutant. These results identify a specific mechanism for allosteric regulation of the CP by the RP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11295493     DOI: 10.1016/s0300-9084(01)01242-1

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  23 in total

1.  Polyubiquitin substrates allosterically activate their own degradation by the 26S proteasome.

Authors:  Dawadschargal Bech-Otschir; Annett Helfrich; Cordula Enenkel; Gesa Consiglieri; Michael Seeger; Hermann-Georg Holzhütter; Burkhardt Dahlmann; Peter-Michael Kloetzel
Journal:  Nat Struct Mol Biol       Date:  2009-01-25       Impact factor: 15.369

Review 2.  New uses for old copper-binding drugs: converting the pro-angiogenic copper to a specific cancer cell death inducer.

Authors:  Di Chen; Q Ping Dou
Journal:  Expert Opin Ther Targets       Date:  2008-06       Impact factor: 6.902

3.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

Review 4.  Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.

Authors:  Joana Loureiro; Hidde L Ploegh
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

Review 5.  Proteasomes and protein conjugation across domains of life.

Authors:  Julie Maupin-Furlow
Journal:  Nat Rev Microbiol       Date:  2011-12-19       Impact factor: 60.633

Review 6.  Effects of ethanol on the proteasome interacting proteins.

Authors:  Fawzia Bardag-Gorce
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

7.  ASK1 negatively regulates the 26 S proteasome.

Authors:  Ji Won Um; Eunju Im; Joongkyu Park; Yohan Oh; Boram Min; Hyun Jung Lee; Jong Bok Yoon; Kwang Chul Chung
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

8.  The asymmetry in the mature amino-terminus of ClpP facilitates a local symmetry match in ClpAP and ClpXP complexes.

Authors:  Maria C Bewley; Vito Graziano; Kathleen Griffin; John M Flanagan
Journal:  J Struct Biol       Date:  2005-12-01       Impact factor: 2.867

Review 9.  The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention.

Authors:  Di Chen; Q Ping Dou
Journal:  Curr Protein Pept Sci       Date:  2010-09       Impact factor: 3.272

10.  Structural insights into proteasome activation by the 19S regulatory particle.

Authors:  Aaron Ehlinger; Kylie J Walters
Journal:  Biochemistry       Date:  2013-05-14       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.